The role of taxanes as a component of neoadjuvant chemotherapy for breast cancer.
Gogas
H
H
First Department of Medicine, Laiko Hospital, University of Athens, Athens, Grece. hgogas@hol.gr
Fountzilas
G
G
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D001952:Bridged-Ring Compounds / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D000077143:Docetaxel; D006801:Humans; D020360:Neoadjuvant Therapy / Q000379:methods*; D017239:Paclitaxel / Q000031:analogs & derivatives* / Q000627:therapeutic use; D043823:Taxoids
D000903:Antibiotics, Antineoplastic; D000972:Antineoplastic Agents, Phytogenic; D001952:Bridged-Ring Compounds; D043823:Taxoids; D000077143:Docetaxel; C080625:taxane; D017239:Paclitaxel